Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants
Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have replaced vitamin K antagonist (VKA) oral anticoagulants as the first-line treatment option for stroke prevention in high-risk patients with atrial fibrillation. With VKA therapy, disease and treatment-related knowledge is associate...
Main Authors: | Jose Raul Valery, Ahmad Marar, George Pujalte, Cynthia Ward, Yousif M. Abdelmoneim, Patrick J. Fitzgerald, Edson Mwakyanjala, Dana M. Harris, Loren Murray, Michael G. Heckman, Launia J. White, Fernando Stancampiano |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Journal of Primary Care & Community Health |
Online Access: | https://doi.org/10.1177/21501319221118806 |
Similar Items
-
Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01) -
Comparison of Migraine Characteristics in Patients With and Without Inflammatory Bowel Disease: A Retrospective Cohort Study
by: Sean M. Sileno, et al.
Published: (2023-03-01) -
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01) -
Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01) -
Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
by: Hyun-Jung Lee, et al.
Published: (2023-02-01)